Stock Taper Total Revenue: RMB 433 million, up 46% year-over-year.
Aesthetic Center Revenue: RMB 282 million, a significant increase of 186% year-over-year.
Gross Margin for Aesthetic Center Business: 27%, reflecting operational efficiency gains.
Net Loss: RMB 49.2 million, compared to RMB 33.1 million in Q1 2025.
Cash Position: RMB 880 million, down from RMB 936.4 million at year-end 2025, attributed to strategic investments in expansion.
Expansion of Aesthetic Centers: Increased to 59 centers across 17 cities, with a net addition of 10 centers since year-end 2025.
User Engagement: Active user base reached over 310,000, with a 52% referral rate for new customers.
Operational Efficiency: 41 centers were profitable, and 48 generated positive operating cash flow.
Innovative Partnerships: Collaborated with Jinbo Biopharmaceutical to launch new products, enhancing the supply chain and product offerings.
Focus on Quality: Established a medical R&D and training center to enhance service quality and physician capabilities.
Q2 Revenue Expectations: Anticipated aesthetic treatment service revenues between RMB 307 million and RMB 317 million, representing year-over-year growth of 112.6% to 119.5%.
Long-term Goals: Aiming for 1,000 centers while optimizing operational performance and enhancing financial metrics.
Increased Net Loss: The net loss widened compared to the previous year, raising concerns about profitability amidst rapid expansion.
Declining Segments: Revenue from information and reservation services fell 34% year-over-year, indicating potential challenges in this segment.
Competitive Pressures: The medical aesthetic industry is experiencing intensified competition, with weaker players expected to exit the market, which could impact overall growth.
Market Outlook: Management remains optimistic about the growth potential in the light medical aesthetic segment, which is evolving towards anti-aging solutions.
User Spending Potential: High repurchase rates among core members suggest opportunities to increase average revenue per user (ARPU) through personalized services and bundled offerings.
Talent Development: Emphasis on rigorous hiring and training standards for physicians, with mechanisms in place to retain high-quality talent amid industry competition.
Service Model Innovations: Introduction of physician-led consultations aims to enhance customer trust and improve service delivery efficiency. This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, challenges, and insights from the Q&A session, providing a comprehensive overview of So-Young's performance and outlook for Q1 2026.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT